Skip to main content
NCBI home page
Gut logoLink to Gut
. 1999 Sep;45(3):416–420. doi: 10.1136/gut.45.3.416

Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1α in alcoholic liver disease

N Fisher 1, D Neil 1, A Williams 1, D Adams 1
PMCID: PMC1727646  PMID: 10446112

Abstract

BACKGROUND—Alcoholic liver disease is associated with increased hepatic expression of monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein 1α (MIP-1α).
AIMS—To determine whether concentrations of chemokines in the peripheral circulation reflect disease activity, and whether chemokine secretion is restricted to the liver or is part of a systemic inflammatory response in alcoholic liver disease.
PATIENTS—Fifty one patients with alcoholic liver disease and 12 healthy controls.
METHODS—Peripheral vein (and hepatic vein in patients undergoing transjugular liver biopsy) chemokine concentrations were measured by ELISA. Chemokine secretion and transcription in isolated peripheral mononuclear cells were assessed using ELISA and in situ hybridisation in patients with severe alcoholic hepatitis.
RESULTS—Serum MCP-1 concentrations were higher in alcoholic hepatitis compared with cirrhosis or healthy controls. MIP-1α concentrations were below the assay sensitivity in most patients. Serum MCP-1 concentrations correlated significantly with serum aspartate aminotransferase and creatinine. In severe alcoholic hepatitis, MCP-1 concentrations were higher in hepatic compared with peripheral veins; in mild alcoholic hepatitis there was no difference. Mononuclear cell secretion of both MCP-1 and MIP-1α was higher in severe alcoholic hepatitis compared with healthy controls, and chemokine mRNA was identified in monocytes.
CONCLUSIONS—Serum MCP-1 concentrations are raised in alcoholic liver disease and reflect severity of hepatic inflammation. Monocyte secretion of both MCP-1 and MIP-1α is increased in severe alcoholic hepatitis. Both intrahepatic sources and peripheral mononuclear cells contribute to the raised serum MCP-1 concentrations.


Keywords: alcoholic liver disease; chemokines; monocyte chemoattractant protein 1; macrophage inflammatory protein 1α

Full Text

The Full Text of this article is available as a PDF (123.6 KB).

Figure 1  .

Figure 1  

Open in a new tab

Serum monocyte chemoattractant protein 1 (MCP-1) concentrations in patients with severe or mild to moderate alcoholic hepatitis, inactive alcoholic cirrhosis, and controls. Thick horizontal bars represent mean values. Concentrations in severe alcoholic cirrhosis were significantly higher than in cirrhotics or controls (p<0.01, Mann-Whitney U test).

Figure 2  .

Figure 2  

Open in a new tab

Paired hepatic and peripheral vein (HV and PV) monocyte chemoattractant protein 1 (MCP-1) concentrations in patients with severe alcoholic hepatitis compared with mild to moderate hepatitis or cirrhosis.

Figure 3  .

Figure 3  

Open in a new tab

Spontaneous peripheral blood mononuclear cell secretion of (A) monocyte chemoattractant protein 1 (MCP-1) and (B) macrophage inflammatory protein 1α (MIP-1α) in patients with severe alcoholic hepatitis and healthy controls. Thick horizontal bars represent mean values.

Figure 4  .

Figure 4  

Open in a new tab

PBMC cytospin preparation hybridised with cDNA for macrophage inflammatory protein 1α (MIP-1α) chemokine mRNA (A, antisense probe; B, sense probe). Positive hybridisation is represented by dark granules, which are seen mostly in association with monocytes (M); lymphocytes (L) are mostly negative.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdullah M. S., Wild G., Jacob V., Milford-Ward A., Ryad R., Zanaty M., Ali M. H., el Nahas A. M. Cytokines and the malnutrition of chronic renal failure. Miner Electrolyte Metab. 1997;23(3-6):237–242. [PubMed] [Google Scholar]
  2. Adams D. H., Hubscher S., Fear J., Johnston J., Shaw S., Afford S. Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation. Transplantation. 1996 Mar 15;61(5):817–825. doi: 10.1097/00007890-199603150-00024. [DOI] [PubMed] [Google Scholar]
  3. Afford S. C., Fisher N. C., Neil D. A., Fear J., Brun P., Hubscher S. G., Adams D. H. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol. 1998 Sep;186(1):82–89. doi: 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  4. Akahoshi T., Kobayashi N., Hosaka S., Sekiyama N., Wada C., Kondo H. In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. Nephrol Dial Transplant. 1995 Dec;10(12):2244–2249. doi: 10.1093/ndt/10.12.2244. [DOI] [PubMed] [Google Scholar]
  5. Armendariz-Borunda J., Seyer J. M., Postlethwaite A. E., Kang A. H. Kupffer cells from carbon tetrachloride-injured rat livers produce chemotactic factors for fibroblasts and monocytes: the role of tumor necrosis factor-alpha. Hepatology. 1991 Nov;14(5):895–900. doi: 10.1002/hep.1840140523. [DOI] [PubMed] [Google Scholar]
  6. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998 Apr 9;392(6676):565–568. doi: 10.1038/33340. [DOI] [PubMed] [Google Scholar]
  7. Bode C., Kugler V., Bode J. C. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987 Feb;4(1):8–14. doi: 10.1016/s0168-8278(87)80003-x. [DOI] [PubMed] [Google Scholar]
  8. Bossink A. W., Paemen L., Jansen P. M., Hack C. E., Thijs L. G., Van Damme J. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood. 1995 Nov 15;86(10):3841–3847. [PubMed] [Google Scholar]
  9. Czaja M. J., Geerts A., Xu J., Schmiedeberg P., Ju Y. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol. 1994 Jan;55(1):120–126. doi: 10.1002/jlb.55.1.120. [DOI] [PubMed] [Google Scholar]
  10. Enomoto N., Ikejima K., Bradford B., Rivera C., Kono H., Brenner D. A., Thurman R. G. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology. 1998 Aug;115(2):443–451. doi: 10.1016/s0016-5085(98)70211-2. [DOI] [PubMed] [Google Scholar]
  11. Hill D. B., Marsano L. S., McClain C. J. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology. 1993 Sep;18(3):576–580. [PubMed] [Google Scholar]
  12. Jiang Y., Beller D. I., Frendl G., Graves D. T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992 Apr 15;148(8):2423–2428. [PubMed] [Google Scholar]
  13. Khoruts A., Stahnke L., McClain C. J., Logan G., Allen J. I. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 1991 Feb;13(2):267–276. [PubMed] [Google Scholar]
  14. Luscinskas F. W., Kiely J. M., Ding H., Obin M. S., Hébert C. A., Baker J. B., Gimbrone M. A., Jr In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol. 1992 Sep 15;149(6):2163–2171. [PubMed] [Google Scholar]
  15. Luster A. D. Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med. 1998 Feb 12;338(7):436–445. doi: 10.1056/NEJM199802123380706. [DOI] [PubMed] [Google Scholar]
  16. Maddrey W. C. Alcoholic hepatitis: pathogenesis and approaches to treatment. Scand J Gastroenterol Suppl. 1990;175:118–130. doi: 10.3109/00365529009093136. [DOI] [PubMed] [Google Scholar]
  17. Maher J. J. Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol. Am J Physiol. 1995 Oct;269(4 Pt 1):G518–G523. doi: 10.1152/ajpgi.1995.269.4.G518. [DOI] [PubMed] [Google Scholar]
  18. Maltby J., Wright S., Bird G., Sheron N. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology. 1996 Nov;24(5):1156–1160. doi: 10.1053/jhep.1996.v24.pm0008903391. [DOI] [PubMed] [Google Scholar]
  19. Marra F., DeFranco R., Grappone C., Milani S., Pastacaldi S., Pinzani M., Romanelli R. G., Laffi G., Gentilini P. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol. 1998 Feb;152(2):423–430. [PMC free article] [PubMed] [Google Scholar]
  20. Masumoto T., Onji M., Horiike N., Ohta Y. Assay of serum interleukin 8 levels in patients with alcoholic hepatitis. Alcohol Alcohol Suppl. 1993;1A:99–102. doi: 10.1093/alcalc/28.supplement_1a.99. [DOI] [PubMed] [Google Scholar]
  21. McClain C., Hill D., Schmidt J., Diehl A. M. Cytokines and alcoholic liver disease. Semin Liver Dis. 1993 May;13(2):170–182. doi: 10.1055/s-2007-1007347. [DOI] [PubMed] [Google Scholar]
  22. Orrego H., Blake J. E., Blendis L. M., Medline A. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology. 1987 Jan;92(1):208–214. doi: 10.1016/0016-5085(87)90861-4. [DOI] [PubMed] [Google Scholar]
  23. Paronetto F. Immunologic reactions in alcoholic liver disease. Semin Liver Dis. 1993 May;13(2):183–195. doi: 10.1055/s-2007-1007348. [DOI] [PubMed] [Google Scholar]
  24. Sheron N., Bird G., Koskinas J., Portmann B., Ceska M., Lindley I., Williams R. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology. 1993 Jul;18(1):41–46. [PubMed] [Google Scholar]
  25. Tanaka Y., Kimata K., Adams D. H., Eto S. Modulation of cytokine function by heparan sulfate proteoglycans: sophisticated models for the regulation of cellular responses to cytokines. Proc Assoc Am Physicians. 1998 Mar-Apr;110(2):118–125. [PubMed] [Google Scholar]
  26. Van Zee K. J., Fischer E., Hawes A. S., Hébert C. A., Terrell T. G., Baker J. B., Lowry S. F., Moldawer L. L. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol. 1992 Mar 15;148(6):1746–1752. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES